SCHEMBL4036896

SCHEMBL4036896

O=C(NC1CCCCC1)C(C1CCCCC1)C1(c2ccncc2)Nc2cc(F)c(Cl)cc2N1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 5/20 0.42
CYP3A4 P08684 3/20 0.42
KCNH2 Q12809 3/20 0.42
POLB P06746 2/20 0.41
MAPK1 P28482 1/20 0.40
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
EPHX1 P07099 2/20 0.38
MAPT P10636 1/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.35
IDO1 P14902 1/20 0.35
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4038777 0.90 CYP3A4 (0.42) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4042942 0.90 CYP3A4 (0.42) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4036578 0.90 KCNH2 (0.48) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4036376 0.90 KCNH2 (0.48) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4038655 0.90 KCNH2 (0.48) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4034374 0.90 KCNH2 (0.48) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4039537 0.90 KCNH2 (0.48) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4036707 0.89 C3AR1 (0.41) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4039331 0.85 NR1H4 (0.44) NR1H4CYP3A4KCNH2POLBNPC1
SCHEMBL4038118 0.85 NR1H4 (0.44) NR1H4CYP3A4KCNH2POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed